1. Home
  2. AGNC vs RGEN Comparison

AGNC vs RGEN Comparison

Compare AGNC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGNC
  • RGEN
  • Stock Information
  • Founded
  • AGNC 2008
  • RGEN 1981
  • Country
  • AGNC United States
  • RGEN United States
  • Employees
  • AGNC N/A
  • RGEN N/A
  • Industry
  • AGNC Real Estate Investment Trusts
  • RGEN Medical/Dental Instruments
  • Sector
  • AGNC Real Estate
  • RGEN Health Care
  • Exchange
  • AGNC Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • AGNC 9.0B
  • RGEN 8.0B
  • IPO Year
  • AGNC 2008
  • RGEN N/A
  • Fundamental
  • Price
  • AGNC $8.83
  • RGEN $118.15
  • Analyst Decision
  • AGNC Buy
  • RGEN Buy
  • Analyst Count
  • AGNC 11
  • RGEN 12
  • Target Price
  • AGNC $9.88
  • RGEN $172.67
  • AVG Volume (30 Days)
  • AGNC 29.5M
  • RGEN 819.3K
  • Earning Date
  • AGNC 04-21-2025
  • RGEN 04-29-2025
  • Dividend Yield
  • AGNC 16.31%
  • RGEN N/A
  • EPS Growth
  • AGNC N/A
  • RGEN N/A
  • EPS
  • AGNC 0.40
  • RGEN N/A
  • Revenue
  • AGNC $584,000,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • AGNC $39.36
  • RGEN $13.93
  • Revenue Next Year
  • AGNC $22.20
  • RGEN $14.35
  • P/E Ratio
  • AGNC $22.22
  • RGEN N/A
  • Revenue Growth
  • AGNC N/A
  • RGEN 4.88
  • 52 Week Low
  • AGNC $7.85
  • RGEN $102.97
  • 52 Week High
  • AGNC $10.85
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • AGNC 46.21
  • RGEN 38.20
  • Support Level
  • AGNC $8.65
  • RGEN $120.11
  • Resistance Level
  • AGNC $9.26
  • RGEN $129.42
  • Average True Range (ATR)
  • AGNC 0.18
  • RGEN 6.02
  • MACD
  • AGNC 0.01
  • RGEN -1.20
  • Stochastic Oscillator
  • AGNC 34.46
  • RGEN 5.96

About AGNC AGNC Investment Corp.

AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: